Journal ArticleDOI
Global Cancer Incidence and Mortality Rates and Trends—An Update
Reads0
Chats0
TLDR
Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates.Abstract:
There are limited published data on recent cancer incidence and mortality trends worldwide. We used the International Agency for Research on Cancer's CANCERMondial clearinghouse to present age-standardized cancer incidence and death rates for 2003-2007. We also present trends in incidence through 2007 and mortality through 2012 for select countries from five continents. High-income countries (HIC) continue to have the highest incidence rates for all sites, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates. Mortality rates from these cancers are declining in many HICs while they are increasing in LMICs. LMICs have the highest rates of stomach, liver, esophageal, and cervical cancer. Although rates remain high in HICs, they are plateauing or decreasing for the most common cancers due to decreases in known risk factors, screening and early detection, and improved treatment (mortality only). In contrast, rates in several LMICs are increasing for these cancers due to increases in smoking, excess body weight, and physical inactivity. LMICs also have a disproportionate burden of infection-related cancers. Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs.read more
Citations
More filters
Journal ArticleDOI
miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer.
Andrea Feliciano,Yoelsis Garcia-Mayea,Luz Jubierre,Cristina Mir,Manuela Hummel,Josep Castellví,Javier Hernández-Losa,Rosanna Paciucci,Irene Sansano,Yilin Sun,Santiago Ramón y Cajal,Hiroshi Kondon,Aroa Soriano,Miguel F. Segura,Alex Lyakhovich,Matilde E. Lleonart +15 more
TL;DR: By inhibiting E2F2 and EMR2, miR-99a represses in vivo the transition of epithelial cells through an EMT process concomitantly with the inhibition of stemness features and consequently decreasing the CSC population.
Journal ArticleDOI
Improving the outcomes in gastric cancer surgery.
TL;DR: In this paper, the authors provide an overview of methods implemented in pre-, intra-and post-operative stage of gastric cancer surgery to improve outcome, including risk assessment using comorbidity index, nutritional status assessment, and frailty assessment.
Journal ArticleDOI
DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
Ssu Chuan Lai,Yu Ting Su,Ching-Chi Chi,Ching-Chi Chi,Yung Che Kuo,Kam-Fai Lee,Yu Chih Wu,Pei Chi Lan,Muh Hwa Yang,Muh Hwa Yang,Te-Sheng Chang,Te-Sheng Chang,Yen Hua Huang +12 more
TL;DR: The DNMT3b plays a critical role in the IL-6-mediated OCT4 expression and the drug sensitivity of sorafenib-resistant HCC, and the p-STAT3 activation increases the DN MT3b/OCT4 which confers the tumor early recurrence and poor prognosis of HCC patients.
Journal ArticleDOI
Copper in tumors and the use of copper-based compounds in cancer treatment.
Daniela Almeida da Silva,Anastasia De Luca,Rosanna Squitti,Mauro Rongioletti,Luisa Rossi,Camila Maria Longo Machado,Giselle Cerchiaro +6 more
TL;DR: In this article, the role of copper in cancer, the effects of copper-complexes on tumor cell death mechanisms, and point to the new copper complexes applicable as drugs, suggesting that they may represent at least one component of a multi-action combination in cancer therapy.
Journal ArticleDOI
Copper in tumors and the use of copper-based compounds in cancer treatment
TL;DR: In this article , the role of copper in cancer, the effects of copper-complexes on tumor cell death mechanisms, and point to the new copper complexes applicable as drugs, suggesting that they may represent at least one component of a multi-action combination in cancer therapy.
References
More filters
Journal ArticleDOI
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
TL;DR: The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed.
Journal ArticleDOI
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R. Aberle,Amanda M. Adams,Christine D. Berg,William C. Black,Jonathan D. Clapp,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,Pamela M. Marcus,JoRean D. Sicks +9 more
TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.
Journal ArticleDOI
The global health burden of infection-associated cancers in the year 2002.
TL;DR: The fraction of the different types of cancer, and of all cancers worldwide and in different regions, has been estimated using several methods; primarily by reviewing the evidence for the strength of the association (relative risk) and the prevalence of infection in different world areas.
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]
J Ferlay,I Soerjomataram,M Ervik,R Dikshit,S Eser,Colin Mathers,M Rebelo,D.M. Parkin,David Forman,Freddie Bray,S Elser,M Ervick,Donald Maxwell Parkin +12 more
Journal ArticleDOI
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
TL;DR: The authors update the incidence trends through 1994 and further consider the trends by age group.